Enhanced synergism of antibiotics with zinc oxide nanoparticles against extended spectrum β-lactamase producers implicated in urinary tract infections
Bibliographic record
Abstract
No abstract is available for this record. The assistant can identify its topic from the title, but cannot infer the study’s results.
Source: Not provided · Quality: missing
Research context
OpenAlex topics: Antibiotic Resistance in Bacteria · Antibiotic Use and Resistance · Antibiotics Pharmacokinetics and Efficacy
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (40)
Show source-provided references
1. Baker C, Pradhan A, Pakstis L, Pochan DJ, Shah SI (2005) Synthesis and antibacterial properties of silver nanoparticles. J Nanosci Technol 5:244–24910.1166/jnn.2005.034 ↗
2. Barbaru S, Davir R, Alexander P, Sithes L, William TC, Ilya R (2008) A natural history of botanical therapeutics. Metabol clin Expt 57(1):3–910.1016/S0026-0495(07)00360-5 ↗
3. Bauer AW, Kirby WMM, Sherries JC, Turch M (1966) Antibiotic susceptibility testing by a standard single disc method. Am J Clin Pathol 45:494–49610.1093/ajcp/45.4_ts.493 ↗
4. Bennet PM (2008) Plasmid encoded antibiotic resistance: acquisition and transfer of antibiotic resistance genes in bacteria. Br J Pharmacol 153:347–35710.1038/sj.bjp.0707607 ↗
5. Bradford M (1976) A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248–25410.1016/0003-2697(76)90527-3 ↗
6. Brayner R, Ferrari-IIious R, Brivois N, Djedit S, Benedetti MF, Fievet F(2006) Toxicological impact studies based on Escherichia coli bacteria in ultrafine ZnO nanoparticles colloidal medium. Nano Lett 6(4):866–87010.1021/nl052326h ↗
7. Bruins RM, Kapil S, Oehme SW (2000) Microbial resistance to metal in the environment. Ecotoxicol Environ 45:198–20710.1006/eesa.1999.1860 ↗
8. Faddin FJ (1980) Biochemical tests for identification of medical bacteria, vol 4. Williams and Williams Co., Baltimore, pp 518–538
9. Fernandez F, Neves P, Gemeiro P, Loura LMS, Prieto M (2007) Ciprofloxacin interaction with bacterial protein OmpF: modeling of FRET from a multi-tryptophan protein trimmer. Biochem Biophys Acta 1768:2822–283010.1016/j.bbamem.2007.07.016 ↗
10. Gleiter (2000) Nanostructerd materials basic concepts. Acta Mat 48:1–1210.1016/S1359-6454(99)00285-2 ↗
11. Huang JY, Liu YX, Liu T, Gan X, Liu XJ (2009) A nitric oxide biosensor based on the photovoltaic effect of nano titanium dioxide on haemoglobin. J Anal Chem 64:735–73710.1134/S1061934809070132 ↗
12. Huet AA, Rayagade JL, Mendiratta K, Seo SM, Kaatz GW (2008) Multidrug efflux pump over expression in Staphylococcus aureus after single and multiple in vitro exposure to biocides and dyes. Microbiol 154:3144–315310.1099/mic.0.2008/021188-0 ↗
13. Jones N, Ray B, Ranjit KT, Manna AC (2008) Antibacterial activity of ZnO nanoparticle suspensions on a broad spectrum microorganisms. FEMS Microb Lett 279:71–7610.1111/j.1574-6968.2007.01012.x ↗
14. Kim SJ, Eunye K, Kyeong NY, Kim J, Park SJ, Lee HJ, Kim SH (2007) Antimicrobial effects of silver nanoparticles. Nanomedicine 3:95–10110.1016/j.nano.2006.12.001 ↗
15. Kumor SA, Chen S (2008) Nanostructured ZnO nanoparticles in chemically modified electrodes for biosensor applications. Anal Lett 41:141–15810.1080/00032710701792612 ↗
16. Langer R (2001) Drug delivery—drugs on target. Science 293:58–5910.1126/science.1063273 ↗
17. Li W, Xie X, Shi Q, Zeng H, Yang Y, Chen Y (2009) Antibacterial activity and mechanism of silver nanoparticles on E. coli. Appl Microbiol Biotechnol 5:1–10
18. Major S, Kumar S, Bhatnagar M, Chopra KL (1986) Effect of hydrogen plasma treatment on transparent conducting oxides. Appl Phys Lett 49:394–39810.1063/1.97598 ↗
19. Marones JR, Elechiguerra JL, Camacho A, Holt K, Kouri JB, Ramirez JT, Yacaman MJ (2005) The bactericidal effect of silver nanoparticles. Nanotechnology 16:2346–235310.1088/0957-4484/16/10/059 ↗
20. Maskell R (1982) Diagnosis of urinary tract infections, its causes and consequences. In: Urinary tract infection. Curr Top Infect Series 3M Edward Arnold. London, pp 21–41
21. Miller G (1959) Use of dinitrosalicyclic acid reagent for determination of reducing sugars. Anal Chem 31:426–42910.1021/ac60147a030 ↗
22. Muhammad R, Baksh S, Abdus S, Khan GM, Muhammad J (2004) Comparative study of various growth media in isolation of urinary tract pathogens. Gomal J Med Sci 2(1):16–19
23. Nicole MP, Harding GK, Norris M (1988) Localization of urinary tract infection in elderly institutionalized women with asymptomatic bacteriurea. J Infect Dis 157(1):65–7010.1093/infdis/157.1.65 ↗
24. Noei H, Qiu H, Wang Y, Loffler E, Woll C, Muhler M (2008) The identification of ZnO nanoparticles by infrared Spectroscopy. Phys Chem 10:7092–7097
25. Padmavathy N, Vijayaraghvan R (2008) Enhanced bioactivity of ZnO nanoparticles—an antimicrobial study. Sci Technol Adv Mater 9:1–710.1088/1468-6996/9/3/035004 ↗
26. Pal S, Tak YK, Joon MS (2007) Does the antibacterial activity of silver nanoparticles depends on the shape of nanoparticle? A study of the Gram-negative bacterium Escherichia coli. App Env Microbiol 73(6):1712–172010.1128/AEM.02218-06 ↗
27. Park H, Go H, Kalme S, Mane RS, Han SH, Yoon MY (2009) Protective antigen detection using horizontally stacked hexagonal ZnO platelets. Anal Chem 81:4280–428410.1021/ac900632n ↗
28. Pen G (2009) Characterization of copper oxide nanoparticles for antimicrobial applications. J Antimicrob Agents 33:587–59010.1016/j.ijantimicag.2008.12.004 ↗
29. Ping L, Juan L, Changzhu W, Quingsheng W, Jian L (2005) Synergistic antibacterial effect of beta-lactam antibiotics combined with silver nanoparticles. Nanotech 16:1912–191710.1088/0957-4484/16/9/082 ↗
30. Raffi M, Hussain F, Bhatti TM, Akther JI, Hameed A, Hasa MM (2008) Antibacterial characterization of silver nnoparticles againt E. coli ATCC-15224. J Mater Sci Technol 24(2):192–196
31. Roy K, Mao H, Huang S, Leong K (1999) Oral gene delivery with chitosan–DNA nanoparticles generates immunologic protection in a murine model of peanut allergy. Nat Med 5:387–39110.1038/7385 ↗
32. Ryan BM, Dougherty TJ, Beaulieu D, Chaung J, Dougherty BA, Barret JF (2001) Efflux in bacteria: what do we really know about it? Expert Opin Invest Drugs 10:1409–142210.1517/13543784.10.8.1409 ↗
33. Sawai J (2003) Quantative evaluation of antimicrobial activities of metallic oxide powders (ZnO, MgO and CaO) by conductimetric assay. J Microbiol Methods 54:177–18210.1016/S0167-7012(03)00037-X ↗
34. Sharma VK, Yungard RA, Lin Y (2009) Silver nanoparticle on E. coli. Adv Colloid Interf Sci 145:83–9610.1016/j.cis.2008.09.002 ↗
35. Thati V, Roy AS, Ambika Prasad MVN, Shivannavar CT, Gaddad SM (2010) Nanostructured zinc oxide enhances the activity of antibiotic against Staphylococcus aureus. J Biosci Tech 1(2):64–69
36. Tiller (2001) Designing surfaces that kill bacteria on contact. Proc Natl Acad Sci USA 98:5981–598710.1073/pnas.111143098 ↗
37. Vaseastha A, Dimova-Malinovaska D (2005) Nanostructured and nanoscale devices, sensors and detectors. Sci Technol Adv Mater 6:312–31810.1016/j.stam.2005.02.018 ↗
38. Wang ZG, Zu XT, Zhu S, Wang LM (2006) Green luminescence originates from surface defects in ZnO nanoparticles. Phys E: Low Dimen Sys Nano 35:199–20210.1016/j.physe.2006.07.022 ↗
39. Wren C, Nie S (1998) Quantum dot bioconjugates for ultra sensitive nonisotopic detection. Science 281:2016–201810.1126/science.281.5385.2016 ↗
40. Yu J, Grinius L, Hooper DC (2002) Nor A functions as a multidrug efflux protein in both cytoplasmic membrane vesicles and reconstituted proteo liposomes. J Bacteriol 184:1370–137710.1128/JB.184.5.1370-1377.2002 ↗